Environment in the lung of cystic fibrosis patients stimulates the expression of biofilm phenotype in Mycobacterium abscessus

被引:6
|
作者
Keefe, Bailey F. [1 ]
Bermudez, Luiz E. [1 ,2 ]
机构
[1] Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA
[2] Oregon State Univ, Dept Microbiol, Coll Sci, Corvallis, OR 97331 USA
关键词
Mycobacterium abscessus; cystic fibrosis; biofilm; lung environment; DNA; infection; phenotypes; PSEUDOMONAS-AERUGINOSA; SUSCEPTIBILITY; SPUTUM;
D O I
10.1099/jmm.0.001467
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Introduction. Pulmonary infections caused by organisms of the Mycobacterium abscessus complex are increasingly prevalent in populations at risk, such as patients with cystic fibrosis, bronchiectasis and emphysema. Hypothesis. M. abscessus infection of the lung is not observed in immunocompetent individuals, which raises the possibility that the compromised lung environment is a suitable niche for the pathogen to thrive in due to the overproduction of mucus and high amounts of host cell lysis. Aim. Evaluate the ability of M. abscessus to form biofilm and grow utilizing in vitro conditions as seen in immunocompromised lungs of patients. Methodology. We compared biofilm formation and protein composition in the presence and absence of synthetic cystic fibrosis medium (SCFM) and evaluated the bacterial growth when exposed to human DNA. Results. M. abscessus is capable of forming biofilm in SCFM. By eliminating single components found in the medium, it became clear that magnesium works as a signal for the biofilm formation, and chelation of the divalent cations resulted in the suppression of biofilm formation. Investigation of the specific proteins expressed in the presence of SCFM and in the presence of SCFM lacking magnesium revealed many different proteins between the conditions. M. abscessus also exhibited growth in SCFM and in the presence of host cell DNA. although the mechanism of DNA utilization remains unclear. Conclusions. In vitro conditions mimicking the airways of patients with cystic fibrosis appear to facilitate M. abscessus establishment of infection, and elimination of magnesium from the environment may affect the ability of the pathogen to establish infection.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Molecular Fingerprinting of Mycobacterium abscessus Strains in a Cohort of Pediatric Cystic Fibrosis Patients
    Harris, Kathryn A.
    Kenna, Dervla T. D.
    Blauwendraat, Cornelis
    Hartley, John C.
    Turton, Jane F.
    Aurora, Paul
    Dixon, Garth L. J.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (05) : 1758 - 1761
  • [32] Immune defects in patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis
    Schuurbiers, Milou M. F.
    Bruno, Mariolina
    Zweijpfenning, Sanne M. H.
    Magis-Escurra, Cecile
    Boeree, Martin
    Netea, Mihai G.
    van Ingen, Jakko
    van de Veerdonk, Frank
    Hoefsloot, Wouter
    ERJ OPEN RESEARCH, 2020, 6 (04) : 1 - 10
  • [33] Risk factors for Mycobacterium abscessus infection in cystic fibrosis patients; a case-control study
    Verregghen, Maarten
    Heijerman, Harry G.
    Reijers, Monique
    van Ingen, Jakko
    van der Ent, Cornelis K.
    JOURNAL OF CYSTIC FIBROSIS, 2012, 11 (04) : 340 - 343
  • [34] Non-Tuberculous Mycobacteria multispecies biofilms in cystic fibrosis: development of an in vitro Mycobacterium abscessus and Pseudomonas aeruginosa dual species biofilm model
    Rodriguez-Sevilla, Graciela
    Garcia-Coca, Marta
    Romera-Garcia, David
    Jairo Aguilera-Correa, John
    Mahillo-Fernandez, Ignacio
    Esteban, Jaime
    Perez-Jorge, Concepcion
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2018, 308 (03) : 413 - 423
  • [35] IgA Serological Response for the Diagnosis of Mycobacterium abscessus Infections in Patients with Cystic Fibrosis
    Le Moigne, Vincent
    Roux, Anne-Laure
    Mahoudo, Helene
    Christien, Gaetan
    Ferroni, Agnes
    Dumitrescu, Oana
    Lina, Gerard
    Bouchara, Jean-Philippe
    Plesiat, Patrick
    Gaillard, Jean-Louis
    Canaan, Stephane
    Hery-Arnaud, Genevieve
    Herrmann, Jean-Louis
    MICROBIOLOGY SPECTRUM, 2022, 10 (03):
  • [36] Eradication of Mycobacterium abscessus following elexacaftor/tezacaftor/ivacaftor initiation in cystic fibrosis
    Chapman, S.
    Lorraine, B.
    Hopkins, E.
    Morton, J.
    RESPIROLOGY, 2023, 28 : 162 - 162
  • [37] Molecular characterization of Mycobacterium abscessus subspecies isolated from patients attending an Italian Cystic Fibrosis Centre
    Teri, Antonio
    Sottotetti, Samantha
    Arghittu, Milena
    Girelli, Daniela
    Biffi, Arianna
    D'Accico, Monica
    Dacco, Valeria
    Gambazza, Simone
    Pizzamiglio, Giovanna
    Trovato, Alberto
    Tortoli, Enrico
    Colombo, Carla
    Cariani, Lisa
    NEW MICROBIOLOGICA, 2020, 43 (03) : 127 - 132
  • [38] Antimycobacterial Activity of Veterinary Antibiotics (Apramycin and Framycetin) against Mycobacterium abscessus: Implication for Patients with Cystic Fibrosis
    Moore, John E.
    Koulianos, Greg
    Hardy, Margaret
    Misawa, Naoaki
    Millar, B. Cherie
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2018, 7 (03) : 265 - 267
  • [39] Unique Features of Mycobacterium abscessus Biofilms Formed in Synthetic Cystic Fibrosis Medium
    Belardinelli, Juan M.
    Li, Wei
    Avanzi, Charlotte
    Angala, Shiva K.
    Lian, Elena
    Wiersma, Crystal J.
    Palcekova, Zuzana
    Martin, Kevin H.
    Angala, Bhanupriya
    de Moura, Vinicius C. N.
    Kerns, Callan
    Jones, Victoria
    Gonzalez-Juarrero, Mercedes
    Davidson, Rebecca M.
    Nick, Jerry A.
    Borlee, Bradley R.
    Jackson, Mary
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [40] Eradication of Mycobacterium abscessus infection in cystic fibrosis with initiation of Elexacaftor/Tezacaftor/Ivacaftor
    McParland, Caoimhe
    Nunn, Matthew
    Marras, Theodore K.
    Chiasson, Meredith
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (01) : 38 - 40